Literature DB >> 15485831

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.

Michelle L Chaisson1, Daniel G Branstetter, Jonathan M Derry, Allison P Armstrong, Mark E Tometsko, Kiyoshi Takeda, Shizuo Akira, William C Dougall.   

Abstract

Signaling through the receptor activator of nuclear factor kappa B (RANK) is required for both osteoclast differentiation and mammary gland development, yet the extent to which RANK utilizes similar signaling pathways in these tissues remains unclear. Mice expressing a kinase-inactive form of the inhibitor of kappa B kinase alpha (IKK alpha) have mammary gland defects similar to those of RANK-null mice yet have apparently normal osteoclast function. Because mice that completely lack IKK alpha have severe skin and skeletal defects that are not associated with IKK alpha-kinase activity, we wished to directly examine osteoclastogenesis in IKK alpha(-/-) mice. We found that unlike RANK-null mice, which completely lack osteoclasts, IKK alpha(-/-) mice did possess normal numbers of TRAP(+) osteoclasts. However, only 32% of these cells were multinucleated compared with 57% in wild-type littermates. A more profound defect in osteoclastogenesis was observed in vitro using IKK alpha(-/-) hematopoietic cells treated with colony-stimulating factor 1 and RANK ligand (RANKL), as the cells failed to form large, multinucleated osteoclasts. Additionally, overall RANKL-induced global gene expression was significantly blunted in IKK alpha(-/-) cells, including osteoclast-specific genes such as TRAP, MMP-9, and c-Src. IKK alpha was not required for RANKL-mediated I kappa B alpha degradation or phosphorylation of mitogen-activated protein kinases but was required for RANKL-induced p100 processing. Treatment of IKK alpha(-/-) cells with tumor necrosis factor alpha (TNF alpha) in combination with RANKL led to partial rescue of osteoclastogenesis despite a lack of p100 processing. However, the ability of TNF alpha alone or in combination with transforming growth factor beta to induce osteoclast differentiation was dependent on IKK alpha, suggesting that synergy between RANKL and TNFalpha can overcome p100 processing defects in IKK alpha(-/-) cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485831     DOI: 10.1074/jbc.M406392200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.

Authors:  Bokyung Sung; Sung-Gook Cho; Mingyao Liu; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

2.  Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.

Authors:  Simone Reuter; Subash C Gupta; Kanokkarn Phromnoi; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Role of NF-κB in the skeleton.

Authors:  Deborah Veis Novack
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

4.  Osteoclasts: what do they do and how do they do it?

Authors:  Steven L Teitelbaum
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

5.  Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.

Authors:  Tajneen Natasha; Misty Kuhn; Owen Kelly; Susan R Rittling
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 6.  Documented and potential research impacts of subclinical diseases in zebrafish.

Authors:  Michael L Kent; Claudia Harper; Jeffrey C Wolf
Journal:  ILAR J       Date:  2012

7.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

8.  Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.

Authors:  Jesse E Otero; Simon Dai; Domenica Foglia; Muhammad Alhawagri; Jean Vacher; Manolis Pasparakis; Yousef Abu-Amer
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

9.  Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.

Authors:  Isra Darwech; Jesse Otero; Muhammad Alhawagri; Simon Dai; Yousef Abu-Amer
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

10.  Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation.

Authors:  Jung Nyeo Chun; Boae Choi; Kyung Wha Lee; Doo Jae Lee; Dong Hoon Kang; Joo Young Lee; In Sung Song; Hye In Kim; Sang-Hee Lee; Hyeon Soo Kim; Na Kyung Lee; Soo Young Lee; Kong-Joo Lee; Jaesang Kim; Sang Won Kang
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.